Influenza Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type ( Molecular Diagnostic Tests, Traditional Diagnostic Tests ); End User ( Reference Laboratories, Hospitals/Clinical Laboratories, Other End Users )

Report Code: TIPBT00002215 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW

Influenza diagnostics comprises of a number of flu tests that are used to detect influenza viruses in respiratory specimens. The most common are called "rapid influenza diagnostic tests." The rapid influenza diagnostic tests work by detecting the parts of the virus (antigens) that stimulate an immune response.

MARKET SCOPE

The "Global Influenza Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the influenza diagnostics market with detailed market segmentation by type, end user and geography. The report provides key statistics on the market status of the leading influenza diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  • Based on type, the global influenza diagnostics market is segmented into molecular diagnostic tests, traditional diagnostic tests.
  • On the basis of end user, the market is segmented into reference laboratories, hospitals/clinical laboratories and other end users.

MARKET DYNAMICS

Drivers

  • Increasing prevalence and incidence of influenza.
  • Rising demand for faster diagnostic test for influenza.
  • Increasing number of patients acquiring infections.

Restraints

  • Variability in test sensitivity and specificity.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The influenza diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the influenza diagnostics market in these regions.

IMPACT OF COVID-19 ON INFLUENZA DIAGNOSTICS MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The global outbreak of COVID-19 has impacted all the industries.

The rising burden of infectious diseases across the globe has increased the demand for infectious disease diagnosis products, including influenza & other diseases. The recent outbreak of the coronavirus disease (COVID-19), which has emerged since December 2019 in Wuhan, China, has caused destruction in several countries across the world. According to the WHO, as of 1st June 2020, there were 6,057,853 confirmed cases and 371,166 confirmed deaths. During this pandemic, it is important to minimize the spread of the disease by early diagnosis.

When compared to influenza with COVID-19, both viruses have a similar disease presentation i.e. they both cause respiratory issues. Moreover, both are transmitted by contact, droplets, and fomites. At earlier stages, COVID-19 patients are misdiagnosed with influenza and due to which its demand has raised in late 2019. However, soon it was realized that factors such as immunity, age group, transmission rate, vaccination, & few others are drastically different in case of COVID-19 & influenza. Thus, after realizing the difference between these two infections, the demand for influenza kits was normalized and the need for a comprehensive approach for diagnosis & treatment has gained importance to combat COVID-19 pandemic.

MARKET PLAYERS

The report covers key developments in the influenza diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from influenza diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for influenza diagnostics in the global market. 

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the influenza diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  • Abbott 
  • Quidel Corporation 
  • BioMérieux
  • BD
  • F. Hoffmann-La Roche Ltd
  • Oxford Biosystems
  • Thermo Fisher Scientific
  • Meridian Bioscience
  • Cepheid
  • altona Diagnostics GmbH

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
 1.1. SCOPE OF THE STUDY
 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
 1.3. MARKET SEGMENTATION
 1.3.1 Influenza Diagnostics Market - By Type
 1.3.2 Influenza Diagnostics Market - By End User
 1.3.3 Influenza Diagnostics Market - By Region
 1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INFLUENZA DIAGNOSTICS MARKET LANDSCAPE
 4.1. OVERVIEW
 4.2. PEST ANALYSIS
 4.2.1 North America - Pest Analysis
 4.2.2 Europe - Pest Analysis
 4.2.3 Asia-Pacific - Pest Analysis
 4.2.4 Middle East and Africa - Pest Analysis
 4.2.5 South and Central America - Pest Analysis
 4.3. EXPERT OPINIONS
5. INFLUENZA DIAGNOSTICS MARKET - KEY MARKET DYNAMICS
 5.1. KEY MARKET DRIVERS
 5.2. KEY MARKET RESTRAINTS
 5.3. KEY MARKET OPPORTUNITIES
 5.4. FUTURE TRENDS
 5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INFLUENZA DIAGNOSTICS MARKET - GLOBAL MARKET ANALYSIS
 6.1. INFLUENZA DIAGNOSTICS - GLOBAL MARKET OVERVIEW
 6.2. INFLUENZA DIAGNOSTICS - GLOBAL MARKET AND FORECAST TO 2028
 6.3. MARKET POSITIONING
7. INFLUENZA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
 7.1. OVERVIEW
 7.2. TYPE MARKET FORECASTS AND ANALYSIS
 7.3. MOLECULAR DIAGNOSTIC TESTS
 7.3.1. Overview
 7.3.2. Molecular Diagnostic Tests Market Forecast and Analysis
 7.3.3. RT-PCR Market
 7.3.3.1. Overview
 7.3.3.2. RT-PCR Market Forecast and Analysis
 7.3.4. Loop-Mediated Isothermal Amplification-Based Assays Market
 7.3.4.1. Overview
 7.3.4.2. Loop-Mediated Isothermal Amplification-Based Assays Market Forecast and Analysis
 7.3.5. Nucleic Acid Sequence-Based Amplification Market
 7.3.5.1. Overview
 7.3.5.2. Nucleic Acid Sequence-Based Amplification Market Forecast and Analysis
 7.3.6. Simple Amplification-Based Assays Market
 7.3.6.1. Overview
 7.3.6.2. Simple Amplification-Based Assays Market Forecast and Analysis
 7.3.7. Other Molecular Diagnostic Tests Market
 7.3.7.1. Overview
 7.3.7.2. Other Molecular Diagnostic Tests Market Forecast and Analysis
 7.4. TRADITIONAL DIAGNOSTIC TESTS
 7.4.1. Overview
 7.4.2. Traditional Diagnostic Tests Market Forecast and Analysis
 7.4.3. Viral Culture Market
 7.4.3.1. Overview
 7.4.3.2. Viral Culture Market Forecast and Analysis
 7.4.4. Serological Assays Market
 7.4.4.1. Overview
 7.4.4.2. Serological Assays Market Forecast and Analysis
 7.4.5. Rapid Influenza Detection Market
 7.4.5.1. Overview
 7.4.5.2. Rapid Influenza Detection Market Forecast and Analysis
 7.4.6. Direct Fluorescent Antibody Market
 7.4.6.1. Overview
 7.4.6.2. Direct Fluorescent Antibody Market Forecast and Analysis
8. INFLUENZA DIAGNOSTICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
 8.1. OVERVIEW
 8.2. END USER MARKET FORECASTS AND ANALYSIS
 8.3. REFERENCE LABORATORIES
 8.3.1. Overview
 8.3.2. Reference Laboratories Market Forecast and Analysis
 8.4. HOSPITALS/CLINICAL LABORATORIES
 8.4.1. Overview
 8.4.2. Hospitals/Clinical Laboratories Market Forecast and Analysis
 8.5. OTHER END USERS
 8.5.1. Overview
 8.5.2. Other End Users Market Forecast and Analysis
9. INFLUENZA DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
 9.1. NORTH AMERICA
 9.1.1 North America Influenza Diagnostics Market Overview
 9.1.2 North America Influenza Diagnostics Market Forecasts and Analysis
 9.1.3 North America Influenza Diagnostics Market Forecasts and Analysis - By Type
 9.1.4 North America Influenza Diagnostics Market Forecasts and Analysis - By End User
 9.1.5 North America Influenza Diagnostics Market Forecasts and Analysis - By Countries
 9.1.5.1 United States Influenza Diagnostics Market
 9.1.5.1.1 United States Influenza Diagnostics Market by Type
 9.1.5.1.2 United States Influenza Diagnostics Market by End User
 9.1.5.2 Canada Influenza Diagnostics Market
 9.1.5.2.1 Canada Influenza Diagnostics Market by Type
 9.1.5.2.2 Canada Influenza Diagnostics Market by End User
 9.1.5.3 Mexico Influenza Diagnostics Market
 9.1.5.3.1 Mexico Influenza Diagnostics Market by Type
 9.1.5.3.2 Mexico Influenza Diagnostics Market by End User
 9.2. EUROPE
 9.2.1 Europe Influenza Diagnostics Market Overview
 9.2.2 Europe Influenza Diagnostics Market Forecasts and Analysis
 9.2.3 Europe Influenza Diagnostics Market Forecasts and Analysis - By Type
 9.2.4 Europe Influenza Diagnostics Market Forecasts and Analysis - By End User
 9.2.5 Europe Influenza Diagnostics Market Forecasts and Analysis - By Countries
 9.2.5.1 Germany Influenza Diagnostics Market
 9.2.5.1.1 Germany Influenza Diagnostics Market by Type
 9.2.5.1.2 Germany Influenza Diagnostics Market by End User
 9.2.5.2 France Influenza Diagnostics Market
 9.2.5.2.1 France Influenza Diagnostics Market by Type
 9.2.5.2.2 France Influenza Diagnostics Market by End User
 9.2.5.3 Italy Influenza Diagnostics Market
 9.2.5.3.1 Italy Influenza Diagnostics Market by Type
 9.2.5.3.2 Italy Influenza Diagnostics Market by End User
 9.2.5.4 Spain Influenza Diagnostics Market
 9.2.5.4.1 Spain Influenza Diagnostics Market by Type
 9.2.5.4.2 Spain Influenza Diagnostics Market by End User
 9.2.5.5 United Kingdom Influenza Diagnostics Market
 9.2.5.5.1 United Kingdom Influenza Diagnostics Market by Type
 9.2.5.5.2 United Kingdom Influenza Diagnostics Market by End User
 9.2.5.6 Rest of Europe Influenza Diagnostics Market
 9.2.5.6.1 Rest of Europe Influenza Diagnostics Market by Type
 9.2.5.6.2 Rest of Europe Influenza Diagnostics Market by End User
 9.3. ASIA-PACIFIC
 9.3.1 Asia-Pacific Influenza Diagnostics Market Overview
 9.3.2 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis
 9.3.3 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis - By Type
 9.3.4 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis - By End User
 9.3.5 Asia-Pacific Influenza Diagnostics Market Forecasts and Analysis - By Countries
 9.3.5.1 Australia Influenza Diagnostics Market
 9.3.5.1.1 Australia Influenza Diagnostics Market by Type
 9.3.5.1.2 Australia Influenza Diagnostics Market by End User
 9.3.5.2 China Influenza Diagnostics Market
 9.3.5.2.1 China Influenza Diagnostics Market by Type
 9.3.5.2.2 China Influenza Diagnostics Market by End User
 9.3.5.3 India Influenza Diagnostics Market
 9.3.5.3.1 India Influenza Diagnostics Market by Type
 9.3.5.3.2 India Influenza Diagnostics Market by End User
 9.3.5.4 Japan Influenza Diagnostics Market
 9.3.5.4.1 Japan Influenza Diagnostics Market by Type
 9.3.5.4.2 Japan Influenza Diagnostics Market by End User
 9.3.5.5 South Korea Influenza Diagnostics Market
 9.3.5.5.1 South Korea Influenza Diagnostics Market by Type
 9.3.5.5.2 South Korea Influenza Diagnostics Market by End User
 9.3.5.6 Rest of Asia-Pacific Influenza Diagnostics Market
 9.3.5.6.1 Rest of Asia-Pacific Influenza Diagnostics Market by Type
 9.3.5.6.2 Rest of Asia-Pacific Influenza Diagnostics Market by End User
 9.4. MIDDLE EAST AND AFRICA
 9.4.1 Middle East and Africa Influenza Diagnostics Market Overview
 9.4.2 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis
 9.4.3 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis - By Type
 9.4.4 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis - By End User
 9.4.5 Middle East and Africa Influenza Diagnostics Market Forecasts and Analysis - By Countries
 9.4.5.1 South Africa Influenza Diagnostics Market
 9.4.5.1.1 South Africa Influenza Diagnostics Market by Type
 9.4.5.1.2 South Africa Influenza Diagnostics Market by End User
 9.4.5.2 Saudi Arabia Influenza Diagnostics Market
 9.4.5.2.1 Saudi Arabia Influenza Diagnostics Market by Type
 9.4.5.2.2 Saudi Arabia Influenza Diagnostics Market by End User
 9.4.5.3 U.A.E Influenza Diagnostics Market
 9.4.5.3.1 U.A.E Influenza Diagnostics Market by Type
 9.4.5.3.2 U.A.E Influenza Diagnostics Market by End User
 9.4.5.4 Rest of Middle East and Africa Influenza Diagnostics Market
 9.4.5.4.1 Rest of Middle East and Africa Influenza Diagnostics Market by Type
 9.4.5.4.2 Rest of Middle East and Africa Influenza Diagnostics Market by End User
 9.5. SOUTH AND CENTRAL AMERICA
 9.5.1 South and Central America Influenza Diagnostics Market Overview
 9.5.2 South and Central America Influenza Diagnostics Market Forecasts and Analysis
 9.5.3 South and Central America Influenza Diagnostics Market Forecasts and Analysis - By Type
 9.5.4 South and Central America Influenza Diagnostics Market Forecasts and Analysis - By End User
 9.5.5 South and Central America Influenza Diagnostics Market Forecasts and Analysis - By Countries
 9.5.5.1 Brazil Influenza Diagnostics Market
 9.5.5.1.1 Brazil Influenza Diagnostics Market by Type
 9.5.5.1.2 Brazil Influenza Diagnostics Market by End User
 9.5.5.2 Argentina Influenza Diagnostics Market
 9.5.5.2.1 Argentina Influenza Diagnostics Market by Type
 9.5.5.2.2 Argentina Influenza Diagnostics Market by End User
 9.5.5.3 Rest of South and Central America Influenza Diagnostics Market
 9.5.5.3.1 Rest of South and Central America Influenza Diagnostics Market by Type
 9.5.5.3.2 Rest of South and Central America Influenza Diagnostics Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INFLUENZA DIAGNOSTICS MARKET
 10.1 North America
 10.2 Europe
 10.3 Asia-Pacific
 10.4 Middle East and Africa
 10.5 South and Central America
11. INDUSTRY LANDSCAPE
 11.1. MERGERS AND ACQUISITIONS
 11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
 11.3. NEW PRODUCT LAUNCHES
 11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INFLUENZA DIAGNOSTICS MARKET, KEY COMPANY PROFILES
 12.1. ABBOTT
 12.1.1. Key Facts
 12.1.2. Business Description
 12.1.3. Products and Services
 12.1.4. Financial Overview
 12.1.5. SWOT Analysis
 12.1.6. Key Developments
 12.2. QUIDEL CORPORATION
 12.2.1. Key Facts
 12.2.2. Business Description
 12.2.3. Products and Services
 12.2.4. Financial Overview
 12.2.5. SWOT Analysis
 12.2.6. Key Developments
 12.3. F. HOFFMANN-LA ROCHE LTD
 12.3.1. Key Facts
 12.3.2. Business Description
 12.3.3. Products and Services
 12.3.4. Financial Overview
 12.3.5. SWOT Analysis
 12.3.6. Key Developments
 12.4. BIOMéRIEUX
 12.4.1. Key Facts
 12.4.2. Business Description
 12.4.3. Products and Services
 12.4.4. Financial Overview
 12.4.5. SWOT Analysis
 12.4.6. Key Developments
 12.5. BD
 12.5.1. Key Facts
 12.5.2. Business Description
 12.5.3. Products and Services
 12.5.4. Financial Overview
 12.5.5. SWOT Analysis
 12.5.6. Key Developments
 12.6. OXFORD BIOSYSTEMS
 12.6.1. Key Facts
 12.6.2. Business Description
 12.6.3. Products and Services
 12.6.4. Financial Overview
 12.6.5. SWOT Analysis
 12.6.6. Key Developments
 12.7. THERMO FISHER SCIENTIFIC
 12.7.1. Key Facts
 12.7.2. Business Description
 12.7.3. Products and Services
 12.7.4. Financial Overview
 12.7.5. SWOT Analysis
 12.7.6. Key Developments
 12.8. MERIDIAN BIOSCIENCE
 12.8.1. Key Facts
 12.8.2. Business Description
 12.8.3. Products and Services
 12.8.4. Financial Overview
 12.8.5. SWOT Analysis
 12.8.6. Key Developments
 12.9. CEPHEID
 12.9.1. Key Facts
 12.9.2. Business Description
 12.9.3. Products and Services
 12.9.4. Financial Overview
 12.9.5. SWOT Analysis
 12.9.6. Key Developments
 12.10. ALTONA DIAGNOSTICS GMBH
 12.10.1. Key Facts
 12.10.2. Business Description
 12.10.3. Products and Services
 12.10.4. Financial Overview
 12.10.5. SWOT Analysis
 12.10.6. Key Developments
13. APPENDIX
 13.1. ABOUT THE INSIGHT PARTNERS
 13.2. GLOSSARY OF TERMS

 

The List of Companies

1. Abbott
2. Quidel Corporation
3. BioMérieux
4. BD
5. F. Hoffmann-La Roche Ltd
6. Oxford Biosystems
7. Thermo Fisher Scientific
8. Meridian Bioscience
9. Cepheid
10. altona Diagnostics GmbH

 

TIPBT00002215
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking